Financial Data and Key Metrics Changes - The Common Equity Tier 1 (CET1) ratio stood at 13.56% as of Q3 2025, with Risk-Weighted Assets (RWA) at 570 billion [2] - The Return on Equity (ROE) was reported at 11.1%, showing a slight increase from the previous period [3] - The Net Interest Margin (NIM) improved by 12 basis points to 1.56% [4] Business Line Data and Key Metrics Changes - The Non-Performing Loan (NPL) ratio was reported at 2.8%, indicating a stable credit quality environment [5] - The company achieved a Profitability Factor (PF) of 30.1%, reflecting strong operational efficiency [6] Market Data and Key Metrics Changes - The company noted a 4% growth in its market share, driven by strategic initiatives and competitive positioning [10] - The NIM is expected to remain stable, with projections indicating a range of 4% to 6% for the upcoming quarters [10] Company Strategy and Development Direction - The management emphasized a focus on enhancing digital banking services to improve customer engagement and operational efficiency [12] - The company is strategically positioning itself to capitalize on emerging market opportunities, particularly in the fintech sector [13] Management Comments on Operating Environment and Future Outlook - Management expressed optimism regarding the economic recovery and its potential positive impact on loan demand and profitability [14] - The company anticipates a stable regulatory environment, which should support its growth initiatives moving forward [19] Other Important Information - The company is actively managing its RWA to optimize capital efficiency, with a focus on maintaining a robust CET1 ratio [21] - There is an ongoing commitment to improving asset quality, with measures in place to monitor and manage NPLs effectively [20] Q&A Session Summary Question: What are the expectations for loan growth in the next quarter? - Management indicated that they expect loan growth to remain strong, driven by increased consumer and business demand [10] Question: How is the company addressing competitive pressures in the market? - The company is enhancing its digital offerings and customer service to differentiate itself from competitors [12] Question: What are the key risks the company is monitoring? - Management highlighted credit risk and regulatory changes as primary concerns, with strategies in place to mitigate these risks [19]

3Q 2025 Business Results CET1 Ratio (Preliminary) 13.56% (Δ6bp QoQ) RWA 348.0 Wtn (+2.3% QoQ) 3Q25 Net Income / EPS 1.42 Wtn / KRW 12,196 ROE / ROTCE (3Q25) 11.1% / 12.5% DPS KRW 570 (Record Date: November 4th ) Share Buyback for FY2025 1.25 Wtn (Completion Rate 74.4%) CET1 ratio remained stable at 13.56%(Δ6bp QoQ) despite market uncertainties Group RWA increased by +8.0 Wtn (+2.3% QoQ) due to KRW depreciation and loan growth, but remains managed within annual budget plan : KRW loan balance increased by +8. ...

Core Insights - Global equity markets experienced broad positive returns in Q3 2025, driven by resilient corporate earnings, enthusiasm for AI, and the U.S. Federal Reserve's first interest rate cut of the year [3][21] - Emerging markets, particularly China, led the gains, supported by a U.S. trade truce and strength in the tech sector [3][4] - The Polaris Global Equity Composite gained 5.04% (net of fees) for the quarter, underperforming the MSCI World Index, which returned 7.36% [5][6] Market Performance - Developed markets saw weaker currencies benefiting export-oriented indices, with Japan's TOPIX Index up 11.0% and the U.K.'s FTSE All-Share Index up 6.9% [4] - The U.S. market, represented by the S&P 500 Index, gained over 8%, primarily due to tech and communication stocks [4] - France and Germany underperformed due to geopolitical and fiscal concerns, with tepid growth projections under new U.S. trade policy [4] Sector Analysis - The healthcare sector was the best performer, with notable gains from pharmaceutical stocks, while financials, consumer discretionary, and IT also contributed positively [5][6] - Health insurers faced challenges, with UnitedHealth Group and CVS Health posting over 10% returns, while Elevance Health's shares dropped sharply due to profit guidance cuts [7] - In IT, Samsung Electronics excelled with strong performance in HBM technology and a significant deal with Tesla for AI chip manufacturing [11] Company Highlights - United Therapeutics Corp. was a top contributor to portfolio performance, driven by positive clinical trial results for its drug Tyvaso, potentially adding $4-5 billion in peak sales [6] - AbbVie, Inc. expects high single-digit revenue growth through 2029, with flagship drugs projected to exceed $31 billion in sales by 2027 [6] - The Carlyle Group Inc. outperformed in the financial sector, up over 20% due to strong fee-based credit and secondaries business [8] Investment Strategy - The current economic environment is characterized by a "two-speed" economy, with a concentrated AI-driven boom amidst subdued growth in other sectors [21][22] - Financials are seen as attractive due to stable net interest margins and loan growth, while defensives like consumer staples and healthcare are expected to perform well [22] - Opportunities in economically-sensitive sectors are being explored, with a focus on industrials benefiting from AI integration and supply chain modernization [22][23]

Group 1 - The core viewpoint is a bullish outlook on Shinhan Financial Group Co., Ltd. (NYSE: SHG) (055550.KS), supported by an analysis of the rate environment, corporate legislation revisions, and capital allocation outlook [1][2]. Group 2 - The research service Asia Value & Moat Stocks targets value investors looking for Asia-listed stocks with significant discrepancies between price and intrinsic value, focusing on deep value balance sheet bargains and wide moat stocks [1][2]. - The service provides a range of watch lists with monthly updates, particularly emphasizing investment opportunities in the Hong Kong market [2].

Core Viewpoint - The article compares Shinhan Financial (SHG) and National Australia Bank Ltd. (NABZY) to determine which stock represents a better undervalued investment opportunity [1] Group 1: Zacks Rank and Earnings Outlook - SHG has a Zacks Rank of 1 (Strong Buy), indicating a positive earnings outlook, while NABZY has a Zacks Rank of 3 (Hold) [3] - The Zacks Rank emphasizes stocks with positive revisions to earnings estimates, suggesting that SHG is experiencing an improving earnings outlook [3][7] Group 2: Valuation Metrics - SHG has a forward P/E ratio of 6.51, significantly lower than NABZY's forward P/E of 18.57 [5] - SHG's PEG ratio is 0.53, while NABZY's PEG ratio is 9.83, indicating that SHG is expected to grow earnings at a more favorable rate relative to its price [5] - SHG's P/B ratio is 0.56, compared to NABZY's P/B of 2.16, further suggesting that SHG is undervalued [6] - Based on these valuation metrics, SHG holds a Value grade of B, while NABZY has a Value grade of D [6]

Core Insights - The article compares Shinhan Financial (SHG) and National Australia Bank Ltd. (NABZY) to determine which stock is a better undervalued investment opportunity [1] Valuation Metrics - SHG has a forward P/E ratio of 6.64, significantly lower than NABZY's forward P/E of 16.83 [5] - SHG's PEG ratio is 0.54, while NABZY's PEG ratio is 9.90, indicating SHG's expected earnings growth is more favorable [5] - SHG's P/B ratio is 0.6, compared to NABZY's P/B of 1.96, suggesting SHG is undervalued relative to its book value [6] Analyst Outlook - SHG holds a Zacks Rank of 1 (Strong Buy), indicating stronger earnings estimate revisions compared to NABZY, which has a Zacks Rank of 2 (Buy) [3][7] - The combination of better estimate revision activity and more attractive valuation metrics positions SHG as the superior option for value investors [7]

Core Insights - The article emphasizes the importance of evaluating a company's cash position over mere profit numbers, as cash is considered the lifeblood of a company and a true indicator of financial health [2][4][5] Company Analysis - Stocks such as Marubeni Corporation (MARUY), Materion Corporation (MTRN), Betterware de México, S.A.P.I. de C.V. (BWMX), Euroseas Ltd. (ESEA), and Shinhan Financial Group Co., Ltd. (SHG) are highlighted as potential investment opportunities due to their rising cash flows [3][10] - Marubeni Corporation has seen an 18.8% increase in its earnings estimate for FY March 2026 over the past week and holds a VGM Score of A [10][12] - Materion Corporation's earnings estimate has improved by 3.9% over the past week, with a current VGM Score of B [13] - Betterware de México's earnings estimate rose by 11.3% in the past month, and it has a VGM Score of A [14] - Euroseas Ltd. has experienced a 2.8% increase in its earnings estimate for the current year, holding a VGM Score of B [15] - Shinhan Financial Group's earnings estimate improved by 7.1% over the last month, and it has a VGM Score of A [16] Cash Flow Analysis - Positive cash flow indicates an increase in liquid assets, allowing companies to meet obligations, reinvest, and return wealth to shareholders, while negative cash flow suggests declining liquidity [6] - Companies must not only maintain positive cash flow but also ensure it is increasing to demonstrate management efficiency and reduced dependency on external financing [7] - A screening process was employed to identify stocks with increasing cash flow, focusing on those whose latest cash flow was at least equal to or greater than the 5-year average cash flow per share [8]

Core Viewpoint - The article emphasizes the importance of confirming the sustainability of stock trends for successful short-term investing, highlighting that price movements should be supported by strong fundamentals and positive earnings estimates [1][2]. Group 1: Stock Performance - Shinhan Financial (SHG) has shown a solid price increase of 34.2% over the past 12 weeks, indicating strong investor interest [4]. - Over the last four weeks, SHG has maintained a price increase of 0.7%, suggesting that the upward trend is still intact [5]. - SHG is currently trading at 92% of its 52-week high-low range, indicating a potential breakout [5]. Group 2: Fundamental Strength - SHG holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises [6]. - The stock has an Average Broker Recommendation of 1 (Strong Buy), reflecting high optimism from the brokerage community regarding its near-term price performance [7]. Group 3: Investment Strategy - The article suggests using the "Recent Price Strength" screen to identify stocks like SHG that are on an uptrend with strong fundamentals [3]. - There are over 45 Zacks Premium Screens available for investors to find stocks that align with their investment strategies [8].

Financial Performance Highlights - The CET1 Ratio reached 13.59%, a QoQ increase of 32bp[2,4] - Net income for 2Q25 was ₩1.55 trillion, up 4.1% QoQ, driven by non-interest income improvements despite higher credit costs[2] - ROE and ROTCE for 1H25 were 11.4% and 12.9% respectively, a YoY increase of 0.7%p[2,3] Balance Sheet and RWA Management - Group RWA decreased by ₩4.1 trillion (1.2% QoQ) to ₩340.6 trillion, due to portfolio adjustments and KRW appreciation[2] - KRW loans increased by ₩1.3 trillion (0.4% QoQ), driven by selective market response and reduction of low-yield assets[2] - Group Total Assets increased by 1.7% YTD to ₩752.7 trillion[10,11] Shareholder Returns - DPS for 2Q25 is ₩570, with a share buyback of ₩800 billion approved, ₩600 billion of which is planned for 2H25[2] - Total share buyback for FY2025 amounts to ₩1.25 trillion, including ₩600 billion in 2H25[2] Digital and SDGs Initiatives - SFG Gross MAU reached 23,580 thousand customers in 1H25[39] - Total Green Finance reached ₩3 trillion for 1H25, achieving 72.3% of the 2030 cumulative target of ₩30 trillion[46,47] Asset Quality - Group NPL ratio stood at 0.80%[30,34] - Loan Loss Allowance was ₩4,356.0 billion[30]

Group 1 - The core comparison is between Shinhan Financial (SHG) and National Australia Bank Ltd. (NABZY) to determine which stock offers better value for investors [1][3] - SHG has a Zacks Rank of 1 (Strong Buy), indicating a stronger improvement in earnings outlook compared to NABZY, which has a Zacks Rank of 3 (Hold) [3][7] - Value investors analyze various traditional metrics to assess if a company is undervalued, including P/E ratio, P/S ratio, earnings yield, and cash flow per share [4][6] Group 2 - SHG's forward P/E ratio is 6.68, significantly lower than NABZY's forward P/E of 16.55, indicating a more attractive valuation for SHG [5] - The PEG ratio for SHG is 0.54, while NABZY's PEG ratio is 12.35, further suggesting that SHG is undervalued relative to its expected earnings growth [5] - SHG has a P/B ratio of 0.59 compared to NABZY's P/B of 1.91, reinforcing SHG's position as a more favorable value option [6]